Express Healthcare
Home  »  News  »  SMT bags tender from Italy

SMT bags tender from Italy

156
Read Article

More than 7000 stents will be supplied to 15 public hospitals in Sicily region over the next two years from the beginning of 2019

India’s leading medical device firm Sahajanand Medical Technologies (SMT) has bagged second tender through its Italian partner Eukon in Sicily region, Italy.

SMT’s Supraflex stent was amongst the top four out of the 20 products to win the tender. The tender is to supply more than 7000 stents to 15 public hospitals in Sicily region over the next two years from the beginning of 2019.

This is the second successive tender won by SMT in Italy. The first tender was bagged for the Emilia Romagna region to deliver approximately 10,000 of its ‘Supraflex’ stents. SMT has successfully commercialised the Emilia tender. By qualifying for the Sicily tender SMT has successfully demonstrated its ability to compete with the best in the world for its drug-eluting coronary stents.

“We have designed a strong growth plan and we are thoroughly living it!” said Gennaro Broya de Lucia, Sales Manager, EUKON. “The combination of a great product like Supraflex along with an experienced and dedicated sales team has been the main driver for this market acceptance” he added. “Supraflex has proved to be a great product” he further continued, “We have seen good product appreciation from our customers and the market response has been incredible. SMT is a great partner with a responsive and structured marketing, sales and quality control team. We are proud to have partnered with SMT.”

Gaurav Goel, Head of Western Europe Operations, SMT explains, “Italy is one of the most rapidly growing market and we see it as an important territory to strengthen our presence in Europe. We are glad to know that the medical fraternity in appreciates our product quality. Our aim is to provide holistic 360° service to our customers starting from first contact to post sales along with continuous clinical evidence generation.”

Comments are closed.

Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
Register Now
close-image
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
close-image